It certainly is an interesting rebuttal to all the cheerleading that has popped up. The stock has had a great run in a short amount of time,it wouldn't surprise me if this article did lead to profit taking by some.
It is an interesting article and it is always good to hear opposing viewpoints. However, this article was poorly researched, and full of baseless innuendo, if not falsehoods. It was also written by a guy who apparently (by his admission) has been burned quite a bit in his boitech/biopharma investments.
Regardless it may have had some effect. Continued progress by the company will outweigh everything else.
I look forward to three positives in the not too distant future: 1) another Zertane deal in another country; 2) positive Ampion results; and 3) analyst coverage. If AMPE can pull those off, I think we can see some huge gains. We'll see.